Wearable Neurostimulation

For Opioid Withdrawal Relief

Safe Science Solutions is the exclusive Canadian distributor and licensed provider of the device in America through select clinic chains.

Wearable Neurostimulation
Wearable Neurostimulation - 4
Wearable Neurostimulation 3
Wearable Neurostimulation - 2

Opioid Epidemic: Societal Issue Without A Solution

Lives Impacted

0 M
Americans who struggle with Opioid Use Disorder (OUD)
0
Opioid Overdose Deaths in 2021
0
Babies born dependent annually

Treatment Barriers

2 Out of 5

Won’t seek care due to fear of withdrawal

>21 Yrs.

With existing beds, time current system needs to detox OUD pop.4

Opioid Withdrawal Treatment Challenges

What if you had an opioid withdrawal treatment that offered:

Less Complexity

  • No need to for patient to experience withdrawal before beginning treatment
  • No known drug interactions (benzos, etc.)
  • No systemic side-effects
  • No misuse or overdose concerns

More Flexibility

  • Quick 5-minute therapy activation
  • Clinically significant symptom relief within 30 minutes
  • No need for extra staff to monitor inductions
  • Ability to use in-patient, out-patient, at home, or at work

Introducing Sparrow Ascent

FDA-Cleared Safe, Comfortable, Drug-Free

Wearable Neurostimulation
  • FDA-cleared Class II Medical Device
  • Integrates seamlessly with any current clinical workflow
  • Makes it easier to deliver high-quality treatment to more patients
  • Less burden on staff means a smoother and more consistent transition to the next phase of recovery.

Providing Total Value

Sparrow Ascent Drives Organization Wide Opportunity To Enhance Care

Evidence Based

Level 1, RCT NIH: NIDA Published

Safe

Non-Addictive, No Diversion Risk, No Known Side Effects

Patient Control

5 Min Activation, No Needed Withdrawal, Zero Needles

Any Setting

No X-Waiver Hosp. to Home Alone or Added

Effective

>50% ↓ in 60 Min 100% of Patients COWS, PCL-5, PHQ-9

Supported

Robust Training Dedicated Team 24/7 Care

What's Included

Everything Needed for Therapy - All In One Kit

Earpiece

28 Comfortable Daily Disposable Earpieces

They’re easy to apply, just like a sticker, and deliver mild electrical stimulation to the nerves on and around the ear.

Patient Controller

Easy-to-Use Patient Controller

It powers the Earpiece and puts the patient in control of the duration and level of stimulation needed for relief.

Cable

Cable

It connects and delivers electrical pulses from the Patient Controller to the Earpiece.

Sparrow Ascent Is

Safe

  • Non-addictive treatment option
  • No known drug interactions or systemic side effects
  • No diversion risk

Comfortable

  • No need to experience withdrawal to begin treatment
  • The patient can control therapy throughout treatment
  • Therapy can be completed at home, work, or on the go


Drug Free

  • Uses mild electric pulses instead of pills
  • No daily clinic visits needed for treatment
  • The patient can control their sobriety date

How It Works

  • Sparrow delivers patient-controlled electrical stimulation transcutaneously (through the skin on and around the ear)
  • Stimulation targets cranial nerve branches of the Trigeminal (CN V) and Vagus (CN X) nerves
  • Activates central brain regions to release endogenous opioids (endorphins)1
  • The endorphins fill the brain’s vacant opioid receptors to reduce or eliminate withdrawal symptoms1

1 Meade, C.S., Lucas, S.E., McDonald, L.J., Fitzmaurice, G.M., Eldridge, J.A., Merrill, N., Weiss, R.D., (2010) A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. Journal of Substance Abuse Treatment, 38(1), 12-21., Han, J. S., & Wang, Q. (1992). Mobilization of specific neuropeptides by peripheral stimulation of identified frequencies. Physiology, 7(4), 176-180., Qureshi, I. S., Datta-Chaudhuri, T., Tracey, K. J., Pavlov, V. A., & Chen, A. C. (2020). Auricular neural stimulation as a new non-invasive treatment for opioid detoxification. Bioelectronic medicine, 6(1), 1-8., Jenkins, D. D., Khodaparast, N., O’Leary, G. H., Washburn, S. N., Covalin, A., & Badran, B. W. (2021). Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome. Frontiers in Human Neuroscience, 15, 110.

No Pills, No Needles, Just Results

Backed By A Level 1 Clinical Trial

0%
84% of participants experienced mild or no withdrawal symptoms after 60 minutes of therapy.
0%
100% of participants sustained a clinically meaningful reduction in withdrawal symptoms by day 3.
0
9 out of 10 participants who completed detox accepted a referral to continue opioid use disorder treatment.

COWS Reduction Throughout Detox

Significant OPIOID Withdrawal Symptom Relief In As Little As 30 Minutes.

PHQ-9 and PCL-5 Results

Helping Support The Recovery Journey

Clinical trial participants also experienced reduction in Depression and PTSD

0%
PHQ-9 = Depression
42.9% of participants had clinically meaningful reduction in PHQ-9 scores at day 5
0
PCL-5 = PTSD
35.7% of participants had clinically meaningful reduction in PCL-5 scores at day 5

Privacy Policy

Copyright © 2024 Safe Science Solutions | All Rights Reserved